COLORADO SPRINGS, Colo.,
Dec. 9, 2014 /PRNewswire/
-- Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company
specializing in cannabis formulation-based drug development and
related consulting, is pleased to announce its President & CEO,
Mr. Raymond C. Dabney, along with
CBIS's Senior Scientific Advisor, Dr. Roscoe M. Moore, Jr., have initiated a
partnership between CBIS and the Constituency for Africa (CFA) to help improve the healthcare
and health-related education infrastructure in Africa. The CFA, a Washington based education and advocacy
organization, will focus attention on improving the healthcare
infrastructure in Africa as part
of its 2015 strategy. Founded in 1990, and now in its
25th year of operation, the CFA has emerged as a leading
organization for mobilizing public and private support for
Africa in Washington, DC. Please visit
http://www.cfa-network.org for more information.
The CFA is planning to launch this African healthcare
infrastructure initiative in February with a stakeholders' forum in
Washington. The forum will bring together senior officials
and leaders in the African Union and African Diplomatic Corps,
Obama Administration, Congress, World Bank, private sector, and the
Diaspora. A high-level advisory committee of experts will
lead this effort with a goal of dramatically improving the
healthcare infrastructure across the African Continent.
CBIS's Dr. Moore, who also serves as the CFA's Interim Chairman,
will co-chair this group. Dr. Moore has an extensive
background stemming from his government service, including as
Assistant U.S. Surgeon General during the George H. W. Bush
Administration.
Cannabis Science Inc., President & CEO, Mr. Raymond C. Dabney will also serve as a co-chair
of this new CFA Health Roundtable. Cannabis Science, based in
Colorado Springs, Colorado, is
dedicated to the discovery and development of cannabis-based
medicines. CBIS will be using its expertise in cannabinoid research
with the CFA's multiple strengths and relationships to help further
the cause in Africa of treating
diseases and symptoms of diseases including cancer, relief from
severe pain, and some AIDS-related illnesses. Through this
effort, CBIS and the CFA will focus on educational systems and the
overall healthcare infrastructure of the Continent.
Dr. Moore stated, "The CFA enjoys direct access to a number of
the key opinion leaders from African leaders to U.S. lawmakers to
international development organizations. Most importantly,
the CFA is highly connected to a range of Diaspora leaders and
experts in healthcare and other fields, who have much to offer in
the effort to help Africa. We can effectively bring these
voices together to generate the needed momentum and investment to
dramatically improve the healthcare infrastructure over the coming
years."
CFA's President and CEO, Mr. Melvin
Foote, believes the time is right to launch an initiative to
strengthen healthcare in Africa,
stating, "The Ebola epidemic has been a tremendous wake-up call
about the weak state of healthcare infrastructure in the countries
strickened by the disease, particularly in the midst of the AIDS
crisis. As Ebola rapidly spread to a number of countries in
and outside of Africa, the entire
world has finally realized that we are all at risk if we continue
to ignore the plight of people in Africa, as any disease is only a plane ride
away. We are extremely welcoming of Mr. Dabney and Cannabis
Science's aggressive leadership."
Since the summer, the Ebola crisis has resulted in more than
6,000 deaths in Liberia,
Sierra Leone and Guinea, and has had a devastating effect on
the economies in these countries, as well as other affected
countries in the region. Schools have been closed, hospitals
have become non-functional and civil society has ground to a
halt. The urgent need for a much improved health
infrastructure in the region and across Africa, has never been so apparent as it is
now. It is clear that Ebola has been able to spread so
quickly in and around urban areas in the region because of the lack
of disease surveillance, of proper training of healthcare workers,
and of basic medicines and needed medical technologies.
The CFA was a pioneer in the battle against HIV and AIDS 14
years ago. Under the leadership of the then Chairman of the
Board, former US Congressman Ron
Dellums, the CFA sized up the pandemic early and went on the
offense and pressed for a global response, proposing an "AIDS
Marshall Plan" to address the various aspects of the
pandemic. The concept of CFA's AIDS Marshall Plan was a
precursor to President George W.
Bush's landmark humanitarian program in 2003, PEPFAR, The US
President's Emergency Plan for AIDS Relief. The massive
funding increases have, among other things, made critical
anti-retroviral therapies widely available in Africa, saving millions of lives.
About Cannabis Science, Inc.
Cannabis Science, Inc.,
takes advantage of its unique understanding of metabolic processes
to provide novel treatment approaches to a number of illnesses for
which current treatments and understanding remain unsatisfactory.
Cannabinoids have an extensive history dating back thousands of
years, and currently, there are a growing number of peer-reviewed
scientific publications that document the underlying biochemical
pathways that cannabinoids modulate. The Company works with leading
experts in drug development, medicinal characterization, and
clinical research to develop, produce, and commercialize novel
therapeutic approaches for the treatment for illnesses caused by
infections as well as for age-related illness. Our initial focus is
on skin cancers and neurological conditions.
Forward-Looking Statements
This Press Release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Act of
1934. A statement containing words such as "anticipate," "seek,"
intend," "believe," "estimate," "expect," "project," "plan," or
similar phrases may be deemed "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995. Some or all of the events or results anticipated by these
forward-looking statements may not occur. Factors that could cause
or contribute to such differences include the future U.S. and
global economies, the impact of competition, and the Company's
reliance on existing regulations regarding the use and development
of cannabis-based drugs. Cannabis Science, Inc., does not undertake
any duty nor does it intend to update the results of these
forward-looking statements.
Cannabis Science, Inc.
Raymond C. Dabney, Director,
President & CEO, Co-Founder
raymond@cannabisscience.com
Tel: 1.310.650.3788
Chad S. Johnson, Esq., Director,
COO, & General Counsel
www.cannabisscience.com
info@cannabisscience.com
Tel: 1.888.777.0658
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cannabis-science-cbis-joins-forces-with-the-constituency-for-africa-cfa-to-focus-on-improving-healthcare-infrastructure-in-africa-in-2015-300006803.html
SOURCE Cannabis Science, Inc.